Cargando…
End-of life medical spending and care pathways in the last 12 months of life: A comprehensive analysis of the national claims database in France
To inform policy makers on efficient provision of end-of-life care, we estimated the 12-month medical expenditures of French decedents in 2015. METHODS: We estimated total medical expenditures by service type and diagnosis category, and analyzed care pathways for breast cancer, dementia, chronic obs...
Autores principales: | Nze Ossima, Arnaud, Szfetel, Daniel, Denoyel, Bénédicte, Beloucif, Omar, Texereau, Joelle, Champion, Louis, Vié, Jean François, Durand-Zaleski, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403027/ https://www.ncbi.nlm.nih.gov/pubmed/37543784 http://dx.doi.org/10.1097/MD.0000000000034555 |
Ejemplares similares
-
Burden of COVID-19 in Córdoba, A Department of Colombia: Results of Disability-Adjusted Life-Years: Carga de COVID-19 en Córdoba, un Departamento de Colombia: Resultados de los Años de Vida Ajustados por Discapacidad
por: Lozano, Ana, et al.
Publicado: (2023) -
Healthcare utilization and cost of Stevens-Johnson syndrome and toxic epidermal necrolysis management in Thailand
por: Dilokthornsakul, P, et al.
Publicado: (2016) -
Economic Evaluation of Factorial Trials: Cost-Utility Analysis of the Atorvastatin in Factorial With Omega EE90 Risk Reduction in Diabetes 2 × 2 × 2 Factorial Trial of Atorvastatin, Omega-3 Fish Oil, and Action Planning
por: Dakin, Helen A., et al.
Publicado: (2020) -
Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in Vietnam
por: Due, Ong The, et al.
Publicado: (2020) -
Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income
por: Tordrup, David, et al.
Publicado: (2020)